Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

World Bank Report Predicts Contracting Global Economy Will Hurt Poorest Countries
The World Bank released a report Monday, projecting "a 2.9 percent contraction in global GDP this year, as rich countries contract by 4.5 percent," the Wall Street Journal reports. "The crisis of the past two years is having dramatic effects on capital flows to developing countries, and the world appears to be entering an era of lower growth," World Bank Chief Economist Justin Lin said (Burns, Wall Street Journal, 6/22).
generic viagra online
One In Six Public Health Workers Won't Work In Emergency Flu Pandemic, According To Ben-Gurion University Of The Negev Researchers
A study conducted by researchers at Ben-Gurion University of the Negev (BGU) and John Hopkins Bloomberg School of Public Health indicates that approximately 16 percent of public health care workers will not report for work in a pandemic flu emergency, regardless of the severity.
News of the day
BSI-201 Enters Phase III In Metastatic Triple Negative Breast Cancer
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its wholly owned subsidiary, BiPar Sciences, announced the initiation of the pivotal Phase III trial for BSI-201 in combination with chemotherapy in patients with metastatic triple-negative breast cancer (mTNBC), defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. BSI-201 is a novel investigational targeted therapy which inhibits poly (ADP-ribose) polymerase (PARP1), an enzyme involved in DNA damage repair.
Medical Devices

Saint Barnabas Medical Center Is Only Hospital In New Jersey To Offer Clinical Trial For The Treatment Of Recurrent Chest Wall Breast Cancer

Some patients who suffer from recurrent cancer at the chest wall now have another option. The Radiation Oncology Department at Saint Barnabas Medical Center is one of a few hospitals nationwide to participate in a study which combines the use of the heat-sensitive chemotherapeutic agent ThermoDox® with microwave hyperthermia, or heat. Depending on risk factors, a large percentage of women with mastectomies may experience recurrent chest wall (RCW) breast cancer. The disease is generally defined as the recurrence of tumor to the area of the initial treatment such as mastectomy. "ThermoDox® combined with hyperthermia offers a unique approach to treating patients with difficult and aggressive recurrence of breast cancer at the chest wall," explains Robert Goodman, M.D., chairman of The Radiation Oncology Department at Saint Barnabas Medical Center an co-principal investigator. "Currently, with no standard of care, women with this type of recurrence often cannot be adequately treated with surgery, radiation, or existing chemotherapy." The clinical trial, referred to as the DIGNITY Study, sponsored by Celsion Corporation [NASDAQ:CLSN], is designed to determine the necessary amount of ThermoDox® needed to treat RCW. Researchers hope such treatment will provide a better standard of care and improve the quality of life for those with the devastating disease. To learn more, please contact Dr. Goodman at 973-322-5630 or visit http://www.clinicaltrials.gov. Saint Barnabas Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009